isoproterenol has been researched along with tanshinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, B; Chen, N; Dong, D; Li, J; Li, X; Liu, Y; Lu, Y; Shan, H; Tan, X; Wang, G; Wang, X; Yang, B; Yang, F; Zhang, P | 1 |
| Cheng, D; He, Z; Sun, C; Xu, Y | 1 |
2 other study(ies) available for isoproterenol and tanshinone
| Article | Year |
|---|---|
Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
Topics: Abietanes; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Signaling; Cardiomegaly; Drugs, Chinese Herbal; Isoproterenol; Medicine, Chinese Traditional; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; RNA, Messenger; Up-Regulation | 2011 |
Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
Topics: Abietanes; Acetylcholine; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Cardiac Pacing, Artificial; Chronic Disease; Disease Models, Animal; Echocardiography; Electrocardiography; Female; Heart Atria; Heart Failure; Heart Rate; Isolated Heart Preparation; Isoproterenol; Rabbits; Refractory Period, Electrophysiological; Time Factors | 2016 |